Tandem Diabetes (TNDM) Insider: RSUs Vest; 1,393 Shares Withheld at $10.82
Rhea-AI Filing Summary
Elizabeth A. Gasser, EVP and Chief Strategy Officer of Tandem Diabetes Care, reported multiple transactions on 08/15/2025 affecting her holdings of TNDM common stock. She acquired 1,503 shares (RSU vesting) and an additional 1,097 shares (RSU vesting), both reported as acquisitions at $0 per share. To satisfy tax withholding on vesting, 805 and 588 shares were withheld and disposed at $10.82 per share; no shares were sold on the open market. She directly beneficially owns 4,509 shares from vested RSUs and 7,677 shares from other RSUs per the table, and indirectly holds 22,949 shares through The Gasser Family Trust, where she is a co-trustee.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider received vested RSUs and had shares withheld for taxes; overall holdings rose modestly with substantial indirect trust ownership.
These entries show routine executive compensation mechanics: two RSU vesting events produced 2,600 shares acquired and triggered withholding of 1,393 shares to cover taxes at $10.82 per share. The transactions are consistent with plan terms and do not indicate open-market sales. Indirect ownership of 22,949 shares via a family trust represents a meaningful ownership stake relative to the direct holdings disclosed here, reinforcing ongoing alignment with shareholders.
TL;DR: Transactions reflect standard equity compensation vesting and tax withholding; disclosures identify trust holdings and filing compliance.
The Form 4 clearly discloses vesting schedules and the tax-withholding mechanism, including citations to the 2023 Long-Term Incentive Plan. The reporting was filed by an attorney-in-fact and includes explanatory footnotes about the trust. No departures, option exercises for cash proceeds, or unusual dispositions are reported, indicating routine governance and disclosure practices.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 1,503 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 1,097 | $0.00 | -- |
| Exercise | Common Stock | 1,503 | $0.00 | -- |
| Tax Withholding | Common Stock | 805 | $10.82 | $9K |
| Exercise | Common Stock | 1,097 | $0.00 | -- |
| Tax Withholding | Common Stock | 588 | $10.82 | $6K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. The securities are held by The Gasser Family Trust dated September 1, 2011, of which Elizabeth A. Gasser is a co-trustee. Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. Awarded on May 23, 2024 pursuant to the 2023 Plan. RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.